Lifestyle
- Regular exercise
- Stress management
- Adequate sleep
Glutathione · GSH · Reduced Glutathione · Master Antioxidant
Glutathione (GSH) levels in the blood, reflecting antioxidant capacity and redox balance.
Reference ranges may vary based on laboratory and population. No standardized range universally accepted.
Glutathione (GSH), also known as reduced glutathione, is a tripeptide composed of glutamine, cysteine, and glycine. It functions as a critical antioxidant within the body, participating in cellular redox reactions to maintain oxidative balance. GSH plays a vital role in detoxifying xenobiotics, protecting protein thiols from oxidation, and regulating the cell cycle. Clinically, GSH is significant due to its involvement in reducing oxidative stress and enhancing immune function. Researchers have found that altered GSH levels are associated with various conditions, including schizophrenia and Parkinson's disease, where oxidative stress is a contributing factor. In the context of longevity and biohacking, GSH is valued for its potential to mitigate age-related oxidative damage, thereby supporting cellular health and longevity. Athletes and biohackers may focus on optimizing GSH levels to enhance recovery and performance. However, researchers observed that GSH levels can be influenced by factors such as age, diet, and environmental toxins. Time-of-day variations and fasting states may also affect GSH measurements, necessitating standardized testing conditions to ensure accurate assessments.
Klinische Bedeutung
Elevated GSH levels may indicate enhanced antioxidant capacity, while reduced levels can suggest oxidative stress or impaired detoxification processes.
Progressively rising GSH levels suggest improved antioxidant capacity. Re-test in 6 months to confirm stability.
Falling GSH levels may indicate increased oxidative stress or impaired synthesis.
Re-test Interval
6 months if outside optimal range
Note:
Consult a healthcare provider before starting supplementation, especially if you have underlying health conditions.
GSH levels may fluctuate throughout the day; morning samples recommended.
Testing Frequency
Annually for health monitoring; more frequently if managing specific health conditions.
Correlated with
Current research suggests that reference ranges for glutathione (GSH) levels in various populations, particularly in relation to specific diseases like schizophrenia and Parkinson's disease, remain debated. Researchers have not yet established optimal GSH targets for different clinical contexts or identified all potential confounders affecting GSH measurements. Additionally, unanswered clinical questions include the precise role of GSH dysregulation in the heterogeneity of schizophrenia and its predictive value for the onset of Parkinson's disease.
1,080
Total Citations
9
Human/RCT
4.4
Avg. Influence
2018
Latest
Researchers explored the molecular mechanisms of protein S-glutathionylation, which involves the reversible binding of glutathione to proteins. They noted its potential role in various diseases, including cataracts and Alzheimer's, emphasizing the need for further investigation into its clinical significance.
This review summarized evidence linking glutathione redox imbalance to various brain disorders. Researchers found that glutathione depletion is associated with neurodegenerative diseases and may serve as a biomarker for diagnosis and treatment strategies.
Researchers conducted a randomized controlled trial to assess the effects of oral glutathione supplementation on body stores in healthy adults. They found that glutathione levels in blood and other compartments increased significantly after supplementation, indicating its bioavailability and potential to reduce oxidative stress.
Researchers reviewed the role of glutathione peroxidase GPX1 in cancer. They found that GPX1 has complex roles in tumor biology and may serve as a potential biomarker for cancer risk, though its associations remain controversial.
Researchers discussed the importance of glutathione as a redox biomarker in mitochondrial diseases. They found that measuring glutathione levels could aid in evaluating mitochondrial dysfunction and guide the development of new therapies.
This review examined glutathione's role in physiological processes, highlighting its importance in antioxidant defense, detoxification, and immune regulation. Researchers found that maintaining proper glutathione levels is essential for health and may aid in treating age-related disorders.
This study focused on in vivo brain glutathione measurement using magnetic resonance spectroscopy. Researchers aimed to establish normal GSH concentrations in different brain areas, which could aid in understanding neurological disorders and GSH's role as a biomarker.
Researchers reviewed the dynamics of glutathione in subcellular compartments and its implications for drug development. They highlighted the importance of understanding GSH regulation in various organelles to inform therapeutic strategies targeting intracellular GSH levels.
This study examined the association between plasma glutathione levels and the risk of prodromal Parkinson's disease. Researchers found that higher plasma glutathione levels were linked to a slower increase in the probability of developing Parkinson's disease over time.
This review focused on microsomal glutathione transferase 1 (MGST1) and its role in cancer and ferroptosis. Researchers highlighted MGST1's protective functions against oxidative stress and its potential implications in cancer progression and therapeutic responses.
13
Total Trials
1,161
Total Enrolled
Oslo University Hospital
180
2024
Plasma alpha Glutathione S transferase
S.LAB (SOLOWAYS)
217
2023
Сhanged glutathione (GSH) levels in erythrocyte hemolysate change in patients with type 2 diabetes mellitus
University of Thessaly
20
2023
Change in glutathione concentration of erythrocytes
University of Thessaly
30
2023
Change in glutathione concentration
Weill Medical College of Cornell University
95
2020
Change in GSH levels of treatment response: measure 1
Société des Produits Nestlé (SPN)
128
2019
Total reduced glutathione
University of Campania Luigi Vanvitelli
260
2017
Alpha-Glutathione-S-Transferase (alpha GST) prediction of advanced fibrosis
Assistance Publique - Hôpitaux de Paris
7
2015
Ratio of reduced glutathione and oxidized glutathione in blood erythrocytes.
Taichung Veterans General Hospital
25
2014
Oxidative stress marker (MDA concentation)
Figen ÖNGÖZ DEDE
60
2013
Biochemical parameters (GSH and GSSG levels, GSH/GSSG ratio )
Chulalongkorn University
38
2011
Biomarkers of oxidative stress, i.e., plasma glutathione (reduced and oxidized forms), urinary 8-hydroxydeoxyguanosine, and urinary total antioxidant status
Milton S. Hershey Medical Center
61
2010
Evaluation of the effect of glutathione on key biomarkers
Arkansas Children's Hospital Research Institute
40
2006
Glutathione redox status (GSH/GSSG)
Research publications about Glutathion over time
10totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer